Trospium Chloride Transport by Mouse Drug Carriers of the Slc22 and Slc47 Families

Background: The muscarinic receptor antagonist trospium chloride (TCl) is used for pharmacotherapy of the overactive bladder syndrome. TCl is a hydrophilic positively charged drug. Therefore, it has low permeability through biomembranes and requires drug transporters for distribution and excretion....

Full description

Bibliographic Details
Main Authors: Matthias Gorecki, Simon F. Müller, Regina Leidolf, Joachim Geyer
Format: Article
Language:English
Published: MDPI AG 2020-12-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/22/1/22
_version_ 1797543943007633408
author Matthias Gorecki
Simon F. Müller
Regina Leidolf
Joachim Geyer
author_facet Matthias Gorecki
Simon F. Müller
Regina Leidolf
Joachim Geyer
author_sort Matthias Gorecki
collection DOAJ
description Background: The muscarinic receptor antagonist trospium chloride (TCl) is used for pharmacotherapy of the overactive bladder syndrome. TCl is a hydrophilic positively charged drug. Therefore, it has low permeability through biomembranes and requires drug transporters for distribution and excretion. In humans, the organic cation transporters OCT1 and OCT2 and the multidrug and toxin extrusion MATE1 and MATE2-K carriers showed TCl transport. However, their individual role for distribution and excretion of TCl is unclear. Knockout mouse models lacking mOct1/mOct2 or mMate1 might help to clarify their role for the overall pharmacokinetics of TCl. Method: In preparation of such experiments, TCl transport was analyzed in HEK293 cells stably transfected with the mouse carriers mOct1, mOct2, mMate1, and mMate2, respectively. Results: Mouse mOct1, mOct2, and mMate1 showed significant TCl transport with Km values of 58.7, 78.5, and 29.3 µM, respectively. In contrast, mMate2 did not transport TCl but showed MPP<sup>+</sup> transport with Km of 60.0 µM that was inhibited by the drugs topotecan, acyclovir, and levofloxacin. Conclusion: TCl transport behavior as well as expression pattern were quite similar for the mouse carriers mOct1, mOct2, and mMate1 compared to their human counterparts.
first_indexed 2024-03-10T13:52:39Z
format Article
id doaj.art-c9b1f38376654357b30704d02682f30a
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-10T13:52:39Z
publishDate 2020-12-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-c9b1f38376654357b30704d02682f30a2023-11-21T02:02:09ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672020-12-012212210.3390/ijms22010022Trospium Chloride Transport by Mouse Drug Carriers of the Slc22 and Slc47 FamiliesMatthias Gorecki0Simon F. Müller1Regina Leidolf2Joachim Geyer3Institute of Pharmacology and Toxicology, Faculty of Veterinary Medicine, Justus Liebig University Giessen, 35392 Giessen, GermanyInstitute of Pharmacology and Toxicology, Faculty of Veterinary Medicine, Justus Liebig University Giessen, 35392 Giessen, GermanyInstitute of Pharmacology and Toxicology, Faculty of Veterinary Medicine, Justus Liebig University Giessen, 35392 Giessen, GermanyInstitute of Pharmacology and Toxicology, Faculty of Veterinary Medicine, Justus Liebig University Giessen, 35392 Giessen, GermanyBackground: The muscarinic receptor antagonist trospium chloride (TCl) is used for pharmacotherapy of the overactive bladder syndrome. TCl is a hydrophilic positively charged drug. Therefore, it has low permeability through biomembranes and requires drug transporters for distribution and excretion. In humans, the organic cation transporters OCT1 and OCT2 and the multidrug and toxin extrusion MATE1 and MATE2-K carriers showed TCl transport. However, their individual role for distribution and excretion of TCl is unclear. Knockout mouse models lacking mOct1/mOct2 or mMate1 might help to clarify their role for the overall pharmacokinetics of TCl. Method: In preparation of such experiments, TCl transport was analyzed in HEK293 cells stably transfected with the mouse carriers mOct1, mOct2, mMate1, and mMate2, respectively. Results: Mouse mOct1, mOct2, and mMate1 showed significant TCl transport with Km values of 58.7, 78.5, and 29.3 µM, respectively. In contrast, mMate2 did not transport TCl but showed MPP<sup>+</sup> transport with Km of 60.0 µM that was inhibited by the drugs topotecan, acyclovir, and levofloxacin. Conclusion: TCl transport behavior as well as expression pattern were quite similar for the mouse carriers mOct1, mOct2, and mMate1 compared to their human counterparts.https://www.mdpi.com/1422-0067/22/1/22trospiumtransportOCTMATEdrug excretiondrug transport
spellingShingle Matthias Gorecki
Simon F. Müller
Regina Leidolf
Joachim Geyer
Trospium Chloride Transport by Mouse Drug Carriers of the Slc22 and Slc47 Families
International Journal of Molecular Sciences
trospium
transport
OCT
MATE
drug excretion
drug transport
title Trospium Chloride Transport by Mouse Drug Carriers of the Slc22 and Slc47 Families
title_full Trospium Chloride Transport by Mouse Drug Carriers of the Slc22 and Slc47 Families
title_fullStr Trospium Chloride Transport by Mouse Drug Carriers of the Slc22 and Slc47 Families
title_full_unstemmed Trospium Chloride Transport by Mouse Drug Carriers of the Slc22 and Slc47 Families
title_short Trospium Chloride Transport by Mouse Drug Carriers of the Slc22 and Slc47 Families
title_sort trospium chloride transport by mouse drug carriers of the slc22 and slc47 families
topic trospium
transport
OCT
MATE
drug excretion
drug transport
url https://www.mdpi.com/1422-0067/22/1/22
work_keys_str_mv AT matthiasgorecki trospiumchloridetransportbymousedrugcarriersoftheslc22andslc47families
AT simonfmuller trospiumchloridetransportbymousedrugcarriersoftheslc22andslc47families
AT reginaleidolf trospiumchloridetransportbymousedrugcarriersoftheslc22andslc47families
AT joachimgeyer trospiumchloridetransportbymousedrugcarriersoftheslc22andslc47families